Lotus Pharm vs Chi Sheng Pharma & Biotech: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Chi Sheng Pharma & Biotech (4111) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Chi Sheng Pharma & Biotech

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYChi Sheng Pharma & BiotechYoY
Oct 2026NT$2.13 billion-22.5%NT$114.3 million+2.2%
Sep 2026NT$2.77 billion+128.0%NT$117.7 million+5.8%
Aug 2026NT$2.11 billion+81.7%NT$118.2 million+6.9%
Jul 2026NT$2.49 billion+3.9%NT$118.8 million-1.2%
Jun 2026NT$3.4 billion+225.5%NT$122.8 million-0.7%
May 2026NT$2.32 billion+105.8%NT$124.9 million+0.3%
Apr 2026NT$3.09 billion+19.9%NT$127.5 million+6.6%
Mar 2026NT$4.35 billion+173.6%NT$118.4 million+5.1%
Feb 2026NT$2.24 billion+131.5%NT$105 million+5.9%
Jan 2026NT$2.05 billion-5.5%NT$133.3 million+23.7%
Dec 2025NT$2.44 billion+66.9%NT$119.7 million-0.9%
Nov 2025NT$1.06 billion-0.2%NT$115.5 million+6.3%
Oct 2025NT$2.75 billion+46.0%NT$111.8 million+9.5%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16